COVID-19-Associated Mucormycosis (CAM): An Updated Evidence Mapping
Salman Hussain(European CanCer Organisation), Miloslav Klugar(Palacký University Olomouc), Simona Slezáková(Masaryk University), Abul Kalam Najmi(Jamia Hamdard), Radim Líčeník(Masaryk University), Abanoub Riad(Masaryk University), Andrea Pokorná(Masaryk University), Jitka Klugarová(Masaryk University), Harveen Baxi
International Journal of Environmental Research and Public Health
September 30, 2021
Cited by 46
Related Papers
The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis
|The Lancet Public Health|2022|373
Diabetic kidney disease: An overview of prevalence, risk factors, and biomarkers
|Clinical Epidemiology and Global Health|2020|157
Prevalence of depression among type 2 diabetes mellitus patients in India: A meta-analysis
|Psychiatry Research|2018|132
Neuroprotective role of astaxanthin in hippocampal insulin resistance induced by Aβ peptides in animal model of Alzheimer’s disease
|Biomedicine & Pharmacotherapy|2018|126
Quantitative neuronal c-Fos and c-Jun expression in Alzheimer’s disease
|Neurobiology of Aging|1998|107